Health Trials

Intermediate Risk Non-Muscle Invasive Bladder Cancer

1

Review clinical trials related to Intermediate Risk Non-Muscle Invasive Bladder Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC)

Participants needed: 454
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Ferring PharmaceuticalsUpdated: Jul 1, 2026Locations: 102
Eligibility criteria

Diagnosed with intermediate risk non-muscle invasive bladder cancer (IR NMIBC) a... [+7]

Current or previous evidence of muscle invasive (muscularis propria) or metastat... [+10]

Read more